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Abstract 
Petasites hybridus (Common butterbur) is extensively used in traditional medicine, and is currently 
gaining interest and popularity as a food supplement and for its medicinal properties. It contains a large 
number of active compounds of potential therapeutic activity, but also toxic pyrrolizidine alkaloids. 
Science-based information is needed to support the developing modern use of this plant, and to direct 
continued safe practice in traditional medicine. The present study focused on the essential oils from 
leaves and rhizomes of the understudied P. hybridus ssp. ochroleucus from the Balkans, and evaluated its 
phytochemistry and potential therapeutic activities (antimicrobial, antioxidant, anti-cholinesterase and 
anti-inflammatory), as well its toxicology potential (acute toxicity in insects and mice). We studied the 
essential oils, which are not commonly used in traditional practices, but have a potential for safe use 
since the toxic pyrrolizidine alkaloids, which are non-volatiles, are usually not present in the distilled 
essential oils. Pyrrolizidine alkaloids were indeed not detected in the essential oils; ingestion of the 
essential oils did not induce toxicity signs in mice, and topical application did not elicit skin irritation in 
humans. The essential oils had no antimicrobial properties against 20 pathogenic bacterial strains, but 
demonstrated good local anti-inflammatory activity in a Carrageenan-induced paw edema test. An insect 
toxicity test demonstrated that the leaf essential oil is an efficient insect repellent, and the demonstrated 
anti-cholinesterase activity suggests a potential for the treatment of neurological conditions. Isopetasin, a 
sesquiterpene found in plants of the genus Petasites, known to have anti-inflammatory effects, was 
present only in the rhizomes essential oil (3.9%), and sesquiterpene lactones concentrations were high, 
likely contributing to the antioxidant activity. 
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Abstract: Petasites hybridus (Common butterbur) is extensively used in traditional medicine, and is 
currently gaining interest and popularity as a food supplement and for its medicinal properties. It 
contains a large number of active compounds of potential therapeutic activity, but also toxic 
pyrrolizidine alkaloids. Science-based information is needed to support the developing modern use 
of this plant, and to direct continued safe practice in traditional medicine. The present study focused 
on the essential oils from leaves and rhizomes of the understudied P. hybridus ssp. ochroleucus from 
the Balkans, and evaluated its phytochemistry and potential therapeutic activities (antimicrobial, 
antioxidant, anti-cholinesterase and anti-inflammatory), as well its toxicology potential (acute 
toxicity in insects and mice). We studied the essential oils, which are not commonly used in 
traditional practices, but have a potential for safe use since the toxic pyrrolizidine alkaloids, which 
are non-volatiles, are usually not present in the distilled essential oils. Pyrrolizidine alkaloids were 
indeed not detected in the essential oils; ingestion of the essential oils did not induce toxicity signs 
in mice, and topical application did not elicit skin irritation in humans. The essential oils had no 
antimicrobial properties against 20 pathogenic bacterial strains, but demonstrated good local anti-
inflammatory activity in a Carrageenan-induced paw edema test. An insect toxicity test 
demonstrated that the leaf essential oil is an efficient insect repellent, and the demonstrated anti-
cholinesterase activity suggests a potential for the treatment of neurological conditions. Isopetasin, 
a sesquiterpene found in plants of the genus Petasites, known to have anti-inflammatory effects, was 
present only in the rhizomes essential oil (3.9%), and sesquiterpene lactones concentrations were 
high, likely contributing to the antioxidant activity.   
Keywords: Petasites; medicinal plant; essential oil; sesquiterpenes; pyrrolizidine alkaloids; toxicity; 
Balkan; anti-inflammatory; skin irritation; insect repellent; anti cholinesterase  
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1. Introduction 
Common butterbur [Petasites hybridus (L.) G.Gaertn., B.Mey. & Scherb] is a perennial herbaceous 
flowering plant of the daisy (Asteraceae) family. It has long rhizomes and large leaves, which develop 
after flowering and can reach up to 60 cm in diameter, and it grows up to 3 feet in height and has a 
history of use in traditional medicine [1]. It is native to Europe, and is present as an introduced species 
in North America and West and North Asia. It is common on riverbanks, in wet meadows and in 
other damp and shady locations [2]. Herbal preparations of P. hybridus have been practiced in 
traditional medicine in Europe for over 900 years, for the treatment of a broad spectrum of human 
aliments [3,4]. The rhizomes with roots (Rhizoma cum radicibus Petasiti) and the leaves (Folium Petasiti) 
are used to treat spastic cough, bronchitis, allergic rhinitis, asthma, migraine, dysmenorrhea, 
hypertension, ulcers, loss of appetite, as well as inflammatory gastrointestinal and genitourinary 
diseases [4–8]. In addition to its traditional use, P. hybridus is increasingly used today for its medicinal 
properties as an alternative medicine [9], and is rapidly gaining popularity as a dietary supplement 
[4]. Commercial preparations of P. hybridus capsules, extracts, powders, tinctures and softgels are 
available nowadays in many countries around the world.  
Although the extracts of P. hybridus are approved by the USA Food and Drug Administration 
for use as dietary supplement, negative side effects (e.g., gastrointestinal problems, nausea, headache, 
drowsiness and halitosis) are known to occur [4]. Toxic effects are mainly attributed to alkaloid 
compounds—pyrrolizidine alkaloids, which are known to cause liver damage and may induce cancer 
[10]—and it is therefore not recommended for self-medication [11]. The concentrations of 
pyrrolizidine alkaloids in commercial preparations are usually below the limit of detection due to the 
production processes [4]. However, traditional processing, which is exercised in the Balkan 
Peninsula, results in potential exposure of the users to high concentrations of pyrrolizidine alkaloids. 
Following the Balkan’s ethnobotanical tradition, preparations of P. hybridus are widespread for the 
treatment of gastrointestinal and parasitic-induced hepatobiliary and respiratory disorders, as well 
as migraine and tension headaches [12–15].  
The present study focused on Petasites hybridus subsp. ochroleucus, (i.e., a subspecies of Petasites 
hybridus) which is spread and used in traditional medicine mainly in the eastern, central and southern 
parts of the Balkans [1,16], and is endemic to the southern Balkan region. Very little information is 
available on this sub-species, which is distinguished from the more common and widely distributed, 
red-flowered subspecies P. hybridus subsp. hybridus, which is common in the northern and western 
parts of the Balkans, as well as in the rest of Europe. We focused on the essential oil of this plant, 
which is a herbal preparation not commonly used in traditional practices of Petasites hybridus and 
therefore has attracted little research-attention so far, but that has a potential for safe use since the 
toxic pyrrolizidine alkaloids are non-volatiles and are therefore usually not present in essential oils.   
To the best of our knowledge, the chemical composition of the essential oil of P. hybridus, subsp. 
ochroleucus has not been studied before, and only limited information is available regarding its 
biological activities, despite the common use of the plant by the people of the Balkans. Variability in 
chemical composition within and between P. hybridus species is known to occur [11,17]. We therefore 
analyzed the chemical profile of the essential oils, as well as their effect on a range of biological and 
toxicological activities. Chemical composition may also vary between plant organs, and we have 
therefore comparatively evaluated the composition and activities of essential oils from leaves and 
rhizomes.  
External application of P. hybridus is uncommon, and it could potentially be a safer mode of 
application. There are indications for external use of P. hybridus in the western Balkan Peninsula, for 
the treatment of rheumatism and musculoskeletal ailments and pains [14]. Additionally, according 
to reports in the 19th century literature from Serbia, it was well known and respected as an external 
remedy, with anti-inflammatory and wound healing properties, and as an effective treatment for 
swellings and skin ulcers [18]. We have therefore also evaluated the skin irritant potential of topical 
applications of the essential oil. 
The overall aim of this project was to evaluate therapeutic and toxicology activities of the 
essential oil of P. hybridus subsp. ochroleucus. The hypotheses guiding the workplan were: (1) 
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Essential oils from various plant parts vary in chemical composition and hence in therapeutic and 
toxicological effects. (2) The essential oils will not cause skin irritation when applied externally. To 
evaluate these hypotheses, we studied: (A) Pytochemistry (chemical profile) of essential oils from the 
leaves (above ground tissue) and rhizomes (below ground tissue) of P. hybridus subsp. ochroleucus. 
(B) Antimicrobial, antioxidant, anti-inflammatory and anti-cholinesterase activities, as well as 
toxicological effects (in mouse and Drosophila), comparatively, for essential oils from the leaves and 
rhizomes. (C) Skin irritation potential in humans, with external application of the leaf and rhizome 
essential oils. Antimicrobial activity was evaluated against 20 pathogenic bacterial strains (10 
laboratory reference strains and 10 strains isolated from human wound swabs). Anti-inflammatory 
activity was studied in a Carrageenan-induced paw edema test with female Sprague Dawley rats. 
2. Results 
The chemical profiles of the essential oils of P. hybridus subsp. ochroleucus are presented in Table 
1. Essential oil from the leaves [yield = 0.015% (v/w), d = 848.0 µg/µL] contained 42 components 
(94.62% of the total oil). Only five compounds had content higher than 3%. These are, in decreasing 
order: Fukinanolide (33.42%), 7-epi-α-Eudesmol (16.14%), Linalool (9.03%), Eremophilene (4.31%) 
and Geramacrene D (4.26%). Essential oil from the rhizome [yield = 0.067% (v/w), d = 914.0 µg/µL] 
contained 60 components (92.97% of total oil). Nine compounds had content higher than 3%. These 
are, in decreasing order: (2E)-Nonenal (11.23%), 1-Nonene (8.57%), Germacrene D (5.01%), α-
Eudesmol (4.52%), Isopetasin (3.93%), α-Bisabolol oxide (3.38%), epi-β-Santalene (3.45%), α-
Santalene (3.36%) and β-Cubebene (3.13%). 
Table 1. Chemical composition of the essential oils of Petasites hybridus subsp. ochroleucus extracted 
by hydrodistillation from rhizome and leaves. 
 Component RTa (min) KILb KIEc Leaves (%) Rhizome (%) 
1. 1-Octene 4.458 788 788.9 – 0.84 
2. 1-Nonene 7.068 887 890.7 1.92 8.57 
3. (3E)-Hepten-2-one 8.17 927 925.3 – 0.4 
4. Myrcene 10.289 988 988.1 0.1 0.1 
5. 1-Decene 10.368 986 990.4 – 0.15 
6. α-Phellandrene 10.908 1002 1005.9 2.46 2.9 
7. o-Cymene 11.561 1022 1024.1 1.48 1.47 
8. (E)-β-Ocimene 12.334 1044 1045.3 0.09 – 
9. Fenchone 13.637 1083 1081.2 – 0.34 
10. Linalool 14.108 1095 1094.2 9.03 0.77 
11. n-Nonanal 14.481 1100 1104.4 0.08 – 
12. p-Menth-3-en-8-ol 16.166 1145 1151.1 – 0.51 
13. (2E)-Nonen-1-al 16.448 1157 1159 0.62 11.23 
14. Thymol methyl ether 18.917 1232 1228.4 0.2 0.1 
15. 1-Octen-3-ol-butanoate 20.634 1280 1277.9 – 0.63 
16. Methyl decanoate 22.218 1323 1324.7 – 0.21 
17. α-Cubebene 22.933 1345 1346.2 – 0.23 
18. α-Longipinene 23.063 1350 1350.1 – 0.57 
19. α-Copaene 23.91 1374 1375.7 1.27 0.76 
20. β-Bourbonene 24.166 1387 1383.4 0.79 1.65 
21. β-Cubebene 24.31 1387 1387.7 1.39 3.13 
22. β-Elemene 24.36 1389 1389.2 1.06 – 
23. Cyperene 24.63 1398 1397.5 – 1.08 
24. α-cis-Bergamotene 25.078 1411 1411.5 – 0.71 
25. α-Santalene 25.313 1416 1419 0.66 3.36 
26. α-trans-Bergamotene 25.726 1432 1432.2 0.15 1.46 
27. Aromadendrene 26.094 1439 1443.9 0.18 0.18 
28. epi-β-Santalene 26.184 1445 1446.7 0.27 3.45 
29. α-Himachalene 26.248 1449 1448.8 0.28 – 
30. (E)-β-Farnesene 26.373 1454 1452.8 0.26 1.34 
31. α-Humulene 26.456 1452 1455.4 0.49 1.68 
32. β-Santalene 26.58 1457 1459.4 – 0.72 
33. 4,5-di-epi-Aristolochene 26.904 1471 1469.7 0.48 0.28 
34. Germacrene D 27.303 1484 1482.5 4.26 5.01 
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35. Eremophilene 27.517 1486 1489.3 4.31 2.35 
36. epi-Cubebol 27.63 1493 1492.8 0.9 0.44 
37. Valencene 27.706 1496 1495.2 0.26 – 
38. α-Muurolene 27.788 1500 1497.9 0.78 – 
39. β-Bisabolene 28.099 1505 1508.2 – 1.61 
40. (Z)-α-Bisabolene 28.178 1506 1510.9 – 0.42 
41. δ-Cadinene 28.395 1522 1518.2 1.26 – 
42. trans-Calamenene 28.492 1521 1521.4 0.37 0.35 
43. α-Cadinene 29.046 1537 1540.1 – 0.91 
44. α-Calacorene 29.217 1544 1545.8 – 0.21 
45. Spathulenol 30.115 1577 1576.1 0.33 – 
46. β-Copaen-4α-ol 30.522 1590 1589.3 0.37 – 
47. Salvial-4(14)-en-1-one 30.65 1594 1594.1 0.18 0.51 
48. β-Atlantol 31.101 1608 1609.8 1.41 0.3 
49. γ-Eudesmol 31.719 1630 1631.8 – 0.6 
50. Cubenol 32.117 1645 1645.8 – 1.25 
51. α-Eudesmol 32.328 1652 1653.3 – 4.52 
52. α-Cadinol 32.4 1652 1655.3 – 0.37 
53. Dihydro eudesmol 32.493 1661 1659.1 – 0.8 
54. 7-epi-α-Eudesmol 32.552 1662 1661.2 16.14 0.69 
55. (E)-Bisabol-11-ol 32.645 1667 1664.5 0.73 0.46 
56. β-Atlantone 32.765 1668 1668.7 – 0.27 
57. β-Bisabolol 32.878 1674 1672.8 – 2.53 
58. (Z)-β-Santalol 34.034 1715 1714.5 0.81 0.67 
59. α-Bisabolol oxide 35.023 1748 1751.5 – 3.38 
60. α-Sinensal 35.111 1755 1754.8 – 1.17 
61. Isopetasin 36.49 1805 1806.6 – 3.93 
62. Fukinanolide 36.949 1824 1824.5 33.42 – 
63. n-Hexadecanol 38.327 1874 1878.2 0.17 – 
64. Palmitic acid 40.532 1959 1967.7 – 1.98 
65. n-Heneicosane 43.801 2100 2106.4 0.22 – 
66. Linoleic acid 44.301 2132 2129.7 – 2.14 
67. Oleic acid 44.691 2141 2147 – 2.62 
68. Larixol 47.191 2265 2260.2 – 0.25 
69. Sempervirol 47.708 2282 2284 – 0.54 
70. 4-epi-Abietol 49.06 2343 2348.8 0.49 0.64 
71. Dehydro abietol 49.447 2368 2367.7 0.29 – 
72. cis-Ferruginol acetate 50.288 2411 2408.9 4.25 2.88 
73. 6-keto-Ferruginol 51.216 2456 2455.6 0.41 0.35 
 Total       94.62 92.97 
a) RT = Retention time; b) KIL = Kovats (retention) index—literature data; c) KIE = Kovats (retention) 
index experimentally determined on HP-5MS column. 
Essential oils from both leaves and the rhizomes of P. hybridus subsp. ochroleucus demonstrated 
antioxidant activity (Table 2), with the activity of the leaves’ essential oils greater than that of the 
rhizomes. Neither of the two essential oils expressed antimicrobial activity against any of the tested 
bacterial strains (20 pathogenic bacterial strains, e.g.: 10 laboratory reference strains and 10 strains 
isolated from human wound swabs), and certain bacterial strains even appeared to grow better in the 
presence of the essential oils (although not statistically significant; data not shown). External (topical) 
application of the essential oils did not cause skin irritation in any of the participating human 
volunteers, and all of the experimental Albino Swiss Webster mice survived the acute toxicity trial.  
Table 2. Antioxidant activity of the essential oils obtained from rhizomes and leaves of Petasites 
hybridus subsp. ochroleucus. 
Sample 
DPPH  
IC50 (mg/mL) 
ABTS  
mg VitC/g 
Essential oil from rhizomes  154.229 ± 0.008  0.082 ± 0.003 
Essential oil from leaves 79.899  ± 0.066 1.255 ± 0.043 
BHA (0.10 mg/mL) 0.093 ± 0.000 2.660 ± 0.005  
Vitamin C (0.10 mg/mL) 0.054 ± 0.001 ND 
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Presented data are averages ± standard deviation (n = 4). Lower IC50 values and higher ABTS values 
indicate higher antioxidant activity. The synthetic antioxidant Butylated hydroxyanisole (BHA) and 
Vitamin C were used as controls. ND: not detected. 
Results obtained from the screening of the interaction of the essential oils with cholinesterase 
from pooled human serum are presented in Table 3. Essential oils from the leaves and rhizomes of P. 
hybridus subsp. ochroleucus inhibited cholinesterase activity, but to a lesser extent then Neositgmin 
bromide, a synthetic cholinesterase inhibitor. The inhibition by the leaves’ essential oil (33.24%) was 
lower than the inhibition by the essential oil from the rhizomes (26.37%). 
Table 3. Anti-cholinesterase activity of essential oils obtained from rhizome and leaves of P. hybridus 
subsp. ochroleucus. 
Sample % Inhibition/Activation 
Essential oil from rhizomes  −33.24 
Essential oil from leaves −26.37 
Neostigmin bromide −96.60 
100 µL of essential oil was diluted with DMSO in the ratio 1:5, making the concentration of the 
essential oil 0.167 µL/mL. Presented results are % of inhibition/activation = [(Ix−I0)/I0] × 100; where I0 
is activity of serum cholinesterase in human blood serum and Ix is activity of human serum 
cholinesterase in the presence of the tested substances, potential inhibitors or activators. 
The anti-inflammatory activity results are presented in Table 4. Essential oil from the rhizome 
significantly decreased edema thickness at the concentrations of 10% (at 1, 4 and 6 h) and 20% (at 4 
and 6 h), and the anti-inflammatory activity increased similarly to the referent indomethacin group. 
Essential oil from leaves decreased edema thickness only at the concentration of 40%, with high 
efficiency throughout the examined duration and a high percent of anti-inflammatory activity, 
similar to the indomethacin group. Lower concentrations of the essential oil from the leaves did not 
show significant results. 
Table 4. Anti-inflammatory activity (in %) of essential oils obtained from rhizome and leaves of P. 
hybridus subsp. ochroleucus. 
Groups Hours 
 1 h 2 h 4 h 6 h 
Control (saline) 
Edema thickness (mm) 2.56 ± 0.84 2.62 ± 0.61 1.99 ± 0.22 2.49 ± 0.366 
Anti-inflammatory activity (%) / / / / 
Indomethacin 
(10mg/kg) 
Edema thickness (mm) 1.30 ± 0.32 b 1.45 ± 0.36 b 0.92 ± 0.55 b 1.15 ± 0.183 b 
Anti-inflammatory activity (%) 49.22% 44.65% 53.76% 53.81% 
Control (DMSO) 
Edema thickness (mm) 2.21 ± 0.80 2.05 ± 0.7 1.98 ± 0.49 2.08 ± 0.42 
Anti-inflammatory activity (%) / / / / 
Rhizome 10% 
Edema thickness (mm) 1.10 ± 0.48 a 1.19 ± 0.68 1.07 ± 0.54 a 1.19 ± 0.45 a 
Anti-inflammatory activity (%) 50.22% 41.95% 45.95% 42.7% 
Rhizome 20% 
Edema thickness (mm) 1.53 ± 0.04 1.34 ± 0.39 1.06 ± 0.34 a 1.16 ± 0.26 a 
Anti-inflammatory activity (%) 30.7% 34.63% 46.46% 44.24% 
Rhizome 40% 
Edema thickness (mm) 1.79 ± 0.66 1.31 ± 0.74 1.64 ± 0.48 1.76 ± 0.41 
Anti-inflammatory activity (%) 19% 36.09% 17.17% 15.22% 
Leaf 10% 
Edema thickness (mm) 2.03 ± 0.77 1.51 ± 0.34 1.57 ± 0.47 1.84 ± 0.43 
Anti-inflammatory activity (%) 8.14% 26.34% 20.7% 11.53% 
Leaf 20% 
Edema thickness (mm) 1.28 ± 0.43 1.24 ± 0.31 1.26 ± 0.56 1.7 ± 0.36 
Anti-inflammatory activity (%) 42.08% 39.51% 36.3% 18.26% 
Leaf 40% 
Edema thickness (mm) 1.09 ± 0.55 1.15 ± 0.35 a 1.01 ± 0.55 a 1.19 ± 0.57 a 
Anti-inflammatory activity (%) 50.67% 43.9% 48.98% 42.78% 
Data are expressed as Mean ± S.D: a,b p < 0.05. a significant difference between experimental group and 
control (DMSO) group. b significant difference between indomethacin group and control (saline) 
group. 
The toxicity test on D. melanogaster revealed that the essential oils from both the rhizomes and 
the leaves is toxic for developing larvae. For both essential oils, significant larvae mortality was noted, 
starting at the concentration of 0.38% (Fischer's exact test, p < 0.01). Estimated 48 h and 96 h LC50s for 
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the rhizome oil were 3.40% and 3.13%, respectively. By comparison, the leaves’ essential oil was four 
times more toxic, with estimated 48 h and 96 h LC50s of 0.84% and 0.80%, respectively (Table 5). 
Prolonged monitoring of pupae (until all individuals reached imago stadium) did not show any 
further significant increase in mortality at the stage of pupa with rhizome essential oil. Only a few 
individuals that turned into pupae could not achieve imago stadium. However, for the leaves’ 
essential oil, prolonged mortality was evident during the pupa stage. In the two highest 
concentrations tested, for both oil types, it was also noted that the larvae grew slower, and both the 
larvae pupae, and adults were visibly smaller compared to the other groups.  
The rhizome oil also affected the development of D. melanogaster larvae, and significantly 
delayed achievement of pupa stadium (Figure 1). The effect was dose-dependent and highly 
significant when compared to the control (ANOVA overall effect p < 0.001 with significant Dunnett's 
procedure, for concentrations of 0.75% and higher; chi-square test overall effect p < 0.0001 with 
Fischer's exact test for each concentration vs. control p << 0.05). Development time is presented in 
Table 5. Compared to the control group, development time for the rhizome essential oil treatment 
was delayed by 24–60 h depending on the concentration used. In the case of the leaf essential oil, it 
was not always possible to estimate the development time due to the high mortalities. At the lower 
concentrations, however, the trend of a delayed pupa stadium was the same as that for the rhizome 
essential oil. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The effect of essential oil from rhizomes of P. hybridus subsp. ochroleucuson on the 
development of D. melanogaster larvae into pupae. The effect is statically significant for each tested 
concentration when compared to the control group (Fischer's exact test p < 0.05).  
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Table 5. Effects of essential oils of Petasites hybridus subsp. ochroleucus obtained from rhizomes and 
leaves on D. melanogaster survival. 
 Essential Oil from Rhizomes 
Estimated 48 h LC50 ± SEM for larvae in w/v %. 95% CI 
in brackets 
3.40 ± 0.34 (2.72–4.06) 
Estimated 96 h LC50 ± SEM for larvae in w/v %. 95% CI 
in brackets 
3.13 ± 0.50 (2.14–4.11) 
Estimated chronic toxicity threshold: LC1 (larva to 
adult). 95% CI in brackets. 
0.03 (N.A.−0.2) 
Concentration in the feed media (w/v %) control 0.19% 0.38% 0.75% 1.5% 3% 
Exposed larvae reaching pupa stadium (%) 98.3 90.0 85.0 85.0 76.7 41.7 
Exposed larvae reaching imago stadium (%) 98.3 90.0 78.3 83.3 71.7 35.0 
DT larva to pupa (days) ± SEM 2.56 ± 0.08 3.25 ± 
0.13 
3.50 ± 
0.37 
3.95 ± 
0.34 
5.02 
± 
0.36 
5.17 ± 
0.46 
DT larva to adult (days) ± SEM 7.10 ± 0.03 
7.81 ± 
0.18 
8.25 ± 
0.58 
9.16 ± 
0.20 
9.85 
± 
0.21 
10.40 ± 
0.56 
 Essential Oil from Leaves 
Estimated 48 h LC50 ± SEM for larvae in w/v %. 95% CI 
in brackets 
0.84 ± 0.40 (0.06–1.62) 
Estimated 96 LC50 ± SEM for larvae in w/v %. 95% CI in 
brackets 
0.80 ± 0.24 (0.32–1.27) 
Estimated chronic toxicity threshold: LC1 (larva to 
adult). 95% CI in brackets. 
0.07 (0.04–0.10) 
Concentration in feed media in w/v % control 0.19% 0.38% 0.75% 
1.5
% 
3% 
Exposed larvae reaching pupa stadium (%) 95 93.3 78.3 36.7 
11.
7 
6.7 
Exposed larvae reaching imago stadium (%) 95 83.3 68.3 21.7 5.0 1.7 
DT larva to pupa (days) ± SEM 
1.51 ± 
0.03 
2.41 ± 
0.26 
6.20 ± 
0.34 
4.79 ± 
1.09 
N.
A.* 
N.A.* 
DT larva to adult (days) ± SEM 
6.23 ± 
0.14 
6.95 ± 
0.19 
10.57 ± 
0.66 N.A.
* 
N.
A.* N.A.
* 
* DT is Development time. Where survival rates were < 25% of the number of individuals in the 
experimental group, DT was not calculated. LC1 is - the toxicity threshold of the toxins concentration. 
3. Discussion 
Plants of the genus Petasites contain large amounts of active compounds such as sesquiterpene 
esters, sesquiterpene lactones and pyrrolizidine alkaloids [3]. Pyrrolizidine alkaloids are toxic [3,4], 
while some of the sesquiterpene esters and sesquiterpene lactones have medicinal properties. 
Primarily petasin and isopetasin sesquiterpene esters are considered as the most valuable 
pharmaceutical components in Petasites plants [3]. Therefore, P. hybridus plants used for 
pharmaceutical purposes, and especially the preparations made from these plants, should ideally 
contain high amounts of petasin/isopetasin, and, most importantly, low amounts of pyrrolizidine 
alkaloids [17,19]. The chemical analysis of the essential oils of P. hybridus ssp. ochroleucus from the 
Balkans revealed low concentrations of isopetasin, no petasin and no pyrrolizidine alkaloids. 
Concentrations of sesquiterpene lactones were, however, high. Isopetasin was present only in the 
rhizome essential oil (3.9%) and absent from the essential oil of the leaves. This concentration is below 
the average petasin/isopetasin concentration found in other preparations of Petasites plants [3]. The 
distribution and the concentration of petasin/isopetasin is often higher in rhizomes than in leaves 
[19], which is in accordance with the present results. Lower concentrations of sesquiterpenes (for 
example, farnesene, bisabolene, cyperene, santalene and germacrene, as well as many others) were 
detected in the rhizome essential oil, compared to the leaves. All the well-known pyrrolizidine 
alkaloids commonly present in Petasites (senecionine, integerrimine, seneciphylline or senkirkine) [3], 
as well as other pyrrolizidine alkaloids common in other genera [20], were below the detection limit 
in the essential oils. This is in accord with pyrrolizidine alkaloids being non-volatiles, which was the 
drive for the selection of essential oils (that are produced by distillation) as the medium of study. 
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Therefore, essential oils of P. hybridus subsp. ochroleucus from the Balkans are of low toxicity, and 
satisfy the pharmaceutical requirement for low pyrrolizidine alkaloids content. However, as 
discussed above, they contain only moderate concentrations of the pharmaceutically active 
petasin/isopetasin, and their medicinal properties are therefore based on the activity of other 
compounds.  
Absence of pyrrolizidine alkaloids in the essential oils is in accordance with the zero mortality 
rate observed, and the lack of behavioral changes, in the albino Swiss Webster mice in the acute 
toxicity trial, as well as with the lack of any adverse reaction following contact with human skin, as 
demonstrated with the skin irritation assay. The observed toxicity in Drosophila flies is therefore 
related to the presence of various terpene and terpene-like compounds. Plants produce many 
terpenes as a natural defense against insects [21]. The essential oil of the P. hybridus subsp. 
ochroleucus leaf, which was four times more toxic to Drosophila than the rhizome essential oil was, 
contained high concentrations of linalool (9.03%) (Table 1), which is used as a fruit fly and mosquito 
insecticide [22,23]. Given that the 48 h LC50 for Drosophila larvae was 0.84% (Table 5), and that 
additional prolonged toxicity hindered pupae ability to reach imago stadium, essential oil from the 
leaves of P. hybridus subsp. ochroleucus can be considered as an efficient insect repellent.  
The anti-inflammatory activity of the essential oils of P. hybridus, and the role of 
petasin/isopetasin, have already been described [24]. In this paper, we examined the anti-
inflammatory activity of essential oils obtained from rhizomes and leaves on the Carrageenan-
induced paw edema model in rats. Anti-inflammatory activity of oil obtained from rhizome, starting 
from the concentration of 10%, is high and immediate, while concentration of 20% leads to significant 
inhibition of edema only after 4 h and repeated applications (Table 4), probably due to the slower 
dermal absorption of higher concentrations and the accompanying slower effects. Although low, the 
concentration of the sesquiterpene ester, isopetasine, in the essential oil obtained from the rhizome 
(3.93%) showed an anti-inflammatory effect after local treatment. The local application mode to the 
inflammation site probably contributed to the anti-inflammatory activity, because it has been shown 
that presence of petasin/isopetasin below 15% is inefficient for medical use. Rhizome essential oil at 
the concentration of 40% did not show significant reduction in paw thickness, which can be associated 
with problem of dermal absorption of high concentrations of this oil, or an inadequately effective 
dose. Unlike the essential oil from the rhizome, essential oil from the leaves was effective in 
suppressing paw edema only at the higher concentrations (statistical significance was obtained at the 
concentration of 40%). The differences in the effects of the essential oils obtained from rhizomes and 
leaves are due to different groups of active compounds present in those two plant organs. 
Sesquiterpenes lactones, which are present at high concentration in leaves’ essential oils 
(fukinanolide, 33.42%), have some medical properties as well [25], so the absence of 
petasin/isopetasin in leaves’ essential oils may be offset by high concentrations of sesquiterpenes 
lactones. This explains the anti-inflammatory effect of the essential oil from the leaves, as well as the 
higher concentration required to obtain the corresponding response. The efficiency of high 
concentrations may also indicate better dermal absorption of the essential oil obtained from the 
leaves. 
Essential oil produced by the leaves had a higher antioxidative activity compared to essential 
oils from the underground parts of the plant, likely due to different chemical composition. Our results 
for the antioxidant activity of the leaves’ essential oil are supported by results for Petasites albus, a 
different species in the Petasites genus, from Iran [26], which also reported moderate antioxidant 
activity for the essential oil of the aerial part of the plant. The essential oil obtained from the leaves 
of P. hybridus subsp. ochroleucus contained high concentrations of sesquiterpene lactones 
(fukinanolide 33.42%) (Table 1). Sesquiterpene lactones of different Petasites species are known to 
have antioxidant activities [25,27–29], therefore it is likely that the higher antioxidant activity of the 
leaves’ vs the rhizome’s essential oil is due to the higher fukinanolide concentration. 
Essential oils from the leaves and rhizomes of P. hybridus had a moderate anti-cholinesterase 
activity, with 33.24% and 26.37% inhibition for leaves and rhizomes essential oil, respectively (Table 
3). Cholinesterase inhibitors are considered to delay the progression of dementia, and for now only 
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several such inhibitors are officially registered. There is therefore a strong interest in identifying such 
compounds. Species from the Petasites genus are traditionally used for the treatment of migraine, 
which suggested their potential for the treatment of other neurological disorders including 
Alzheimer's disease e.g., acting as acetylcholinesterase and butyrylcholinesterase inhibitors. The 
results indeed demonstrate an anticholinergic activity of the tested essential oils, and therefore their 
a potential value for the the treatment of neurological disorders, acting as AChE and BuChE 
inhibitors. 
4. Materials and Methods  
4.1. Plant Material 
Petasites hybridus subsp. ochroleucus, (a subspecies of Petasites hybridus) was the plant material 
studied in the project. This subspecies is spread mainly in the eastern, central and southern parts of 
the Balkan Peninsula [1,16], and is endemic to the southern Balkan region. It is distinguished from 
the more common and widely distributed, red-flowered subspecies P. hybridus subsp. hybridus, 
which is related more to the northern and western parts of the Balkans, as well as to the rest of Europe. 
Leaves and rhizomes of P. hybridus subsp. ochroleucus were collected in September 2014 from 
natural habitats, close to the village of Petačinci (42°52'50 N; 22°40'19.17 E), Dimitrovgrad, 
southeastern Serbia. Voucher specimens were deposited in the “Herbarium Moesiacum Niš” (HMN) 
of the Department of Biology and Ecology, Faculty of Science and Mathematics, University of Niš 
under the acquisition number 10,800. The official name of the species and status has been checked 
with http://www.theplantlist.org on October 20, 2017. 
4.2. Essential-Oil Extraction and Chemical Analyses 
The essential oil was extracted from fresh rhizomes and leaves by hydrodistillation for 4 h using 
a Clevenger-type apparatus. The extracted oil was dried over anhydrous sodium sulfate and stored 
at 4 °C until further use. Chemical profile of the essential oils was obtained by GC and GC-MS 
analyses. The GC analysis was performed on a GC HP-5890 II apparatus, equipped with a split–
splitless injector, an HP-5MS capillary column (30 m × 0.25 mm, 0.25 µm film thickness) using helium 
as the carrier gas (1 mL/min), and a flame ionization detector. Operating conditions were as 
previously reported [30]. 
Comparison of Kovats retention indices [applying calibrated automated mass spectral 
deconvolution and identification system software (AMDIS ver. 2.64)], in combination with the SIA 
resolution method [31], was used for detection of the compounds. Spectral data were compared with 
the available literature [32], while obtained mass spectra were compared to those from Wiley 275 and 
NIST/NBS libraries using various search engines. The retention indices were obtained by co-injection 
with a standard aliphatic hydrocarbons C7–C40 mixture. 
Essential oils from leaves and rhizome are complex systems containing numerous compounds, 
as is shown in Figure S1 (supplemental). Occurrence of the overlapped and embedded peaks is 
evident in the total ion chromatogram (TIC), as shown in the result of gas chromatography-mass 
spectrometry (GC-MS) analysis, especially with regard to teropenoids/sesquiterpenoids (compounds 
16–62). First, the peaks from TICs obtained by GC-MS were identified by applying SIA. AMDIS was 
used for the deconvolution of these peaks and extraction of characteristic ion peaks originating from 
the specific compounds. After deconvolution, the purified mass spectrum of each peak was compared 
with the National Institute of Standard and Technology (NIST) 08 database or the mass spectra of 
standards.  
Three examples of this procedure are presented for compounds No. 54, 61 and 62 (Figures S1–
S3). 
4.3. Antioxidant Activity of the Essential Oils  
Antioxidant activity of the essential oils from leaves and rhizomes was tested by DPPH (2,2-
diphenyl-1-picrylhydrazyl) and ABTS [2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid)] 
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assays, as previously described [30], using a Shimadzu, UV-Visible PC 1650 spectrophotometer 
(Tokyo, Japan). Data analysis was performed with OriginPro 8.0 software (Northampton, MA, USA). 
4.4. Antimicrobial Activity of the Essential Oils 
The antimicrobial activity of the essential oils extracted from P. hybridus subsp. ochroleucus was 
evaluated against 20 pathogenic bacterial strains: 1) A total of 10 laboratory reference strains from 
the American Type Culture Collection (ATCC)—Staphylococcus aureus ATCC 6538, S. epidermidis 
ATCC 12228, Streptococcus pyogenes ATCC 19615, Enterococcus faecalis ATCC 19433, Propionibacterium 
acnae ATCC 11827 [from group of Gram-positive bacteria], Escherichia coli ATCC 9863, Pseudomonas 
aeruginosa ATCC 9027, Acinetobacter boumanii ATCC 196060, Proteus mirabilis ATCC 12453 and 
Klebsiella pneumoniae ATCC 10031 (from group of Gram-negative bacteria); and 2) A total of 10 
bacterial strains isolated from human wound swabs—sStaphylococcus aureus, S. epidermidis, 
Streptococcus pyogenes, Enterococcus faecalis, Propionibacterium acnae, Escherichia coli, Pseudomonas 
aeruginosa, Acinetobacter sp., Proteus mirabils and Klebsiella sp. (Sorce: Institute of Public Health in Novi 
Sad, Serbia). 
The antibacterial activity of the essential oils against the selected bacteria was evaluated in vitro, 
by Micro-Well Dilution Assay [33], as was previously described [30]. All experiments were performed 
in triplicates, and two growth controls, consisting of the corresponding medium with 10% DMSO (as a 
negative control) and antibiotic Doxycycline (as a positive control), were included (the concentration of 
Doxycycline ranged from 0.005 to 10.0 mg/mL). Bacterial growth was determined by adding 20 µL of 
0.5% triphenyl tetrazolium chloride (TTC) aqueous solution to the plate [34]. Minimal inhibitory 
concentration (MIC) was defined as the lowest concentration of the oil that inhibited visible growth (red 
colored pellet on the bottom of the wells after the addition of TTC). For the determination of the minimal 
bactericidal concentration (MBC), broth was taken from each well that did not exhibit visible growth, 
and inoculated in Mueller Hinton agar for 24 h at 37 °C. MBC was defined as the lowest oil 
concentration that killed 99.9% of the bacterial cells.  
4.5. Determination of the Skin Irritation Potential of the Essential Oils 
The skin irritation potential of P. hybridus subsp. ochroleucus oil was determined in 30 male and 
female healthy volunteers (aged 18–30 years) who showed no signs of dermatological diseases. All 
volunteers signed an informed consent form after having received a full explanation of the test 
objectives, procedures and foreseeable risks to subjects. A piece of filter paper saturated (30 µL/cm2) 
either with undiluted P. hybridus oils or aqueous solution of sodium lauryl sulfate (20% w/v, positive 
control substance) was applied on the skin of the antecubital area of the arm and tightly covered by 
surgical tape. After 4 h of exposure, the patches were removed, and the sites of application were 
gently washed with water. The skin was examined and scored at 24, 48 and 72 h after patch removal. 
Skin reactions were scored, as previously suggested [35], by using a four-point scale.  
4.6. Acute Toxicity 
Albino Swiss Webster mice of either sex (males, 39–46 g; and females, 31–35 g) from the Oswaldo 
Cruz Foundation breeding stock were used for the study. Mice were housed, cared and handled in 
accordance with the Faculty of Medicine, University of Niš-approved guidelines and regulations 
from 03.07.2007, directed by the government of Serbia, Republic of Serbia Official Gazette No. 37/91, 
50/92, 33/93, 52/93, 53/95, 52/96, 48/94, and 25/2000 (health protection of animals). The animals were 
separated by sex and housed as is described by Mihajilov-Krstev (2014) [30]. All mice had free access 
to tap water and were fed ad libitum. A single dose of oil of P. hybridus obtained from leaves and 
rhizome, diluted in corn oil, was given by gavages to male (0, 1250, 1500 and 2000 mg/kg body 
weight) and female (0, 1250, 1500, 2000, 2500 and 5000 mg/kg body weight) mice. An untreated 
control group was included as well. The mice were observed over 14 days for signs of toxicity or 
mortality. The procedure was repeated, for the oils extracted from both the underground and the 
aerial plant parts, separately. 
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4.7. Anti-Cholinesterase Activity 
Inhibition of human serum cholinesterase was measured spectrophotometrically using a 
Konelab 20 analyzer (Thermofisher Scientific, Helsinki, Finland) with flow thermostated cells, length 
7 mm (at 405 nm wavelength). Anti-cholinesterase activity was measured as described before [36]. 
Butyrylthiocholine iodide (purity > 99%), dithio-nitro benzoic acid (DTNB) and neostygmine 
bromide were purchased from Sigma Co., St. Louis, Missouri, USA. All other chemicals and reagents 
used [NaH2PO4-Na2HPO4, butylhydroxytoluene (BHT), dimethilsulphoxid (DMSO)] were purchased 
from Merck, Darmstadt, Germany. 
4.8. Anti-Inflammatory Activity: Carrageenan-Induced Paw Edema 
Anti-inflammation activity of the essential oils was determined on Carrageenan-induced paw 
edema in Sprague Dawley rats, following Amdekar et al. (2012) [37,38]. Female Sprague Dawley rats 
(180–250 g) were divided into nine groups of five animals per group. In all groups, 0.1 mL, 1% w/v λ-
carrageenan analytical grade (Sigma-Aldrich Chemie Gmbh., Munich, Germany) in normal saline 
was injected into the subplantar tissue of the right hind paw. Plant essential oils, obtained from 
rhizomes and leaves, were dissolved separately in 2.5% DMSO (final volume 50 µL) and applied on 
the right hind paw of rats from the test groups, in concentrations of 10%, 20% or 40%. Oil was applied 
twice: first, immediately after the carrageenan injection, and again 3 hours later. The same volume 
(50 µL) of DMSO was applied to the right paw of animals from the control group. Paw thickness was 
measured before the carrageenan injection and 1, 2, 4 and 6 hours after, using a digital caliper. 
Edema thickness (mm) represents increases in the paw thickness at different time intervals after 
the carrageenan injection, relative to the values obtained before injection. Anti-inflammatory activity 
(edema inhibition) was calculated as anti-inflammatory activity (%) = (C–T)/(C) ×100, where C 
represents edema thickness in the control group, and T is the edema thickness in the test group. 
Indomethacin (10 mg/kg, p.o.) dissolved in saline was used as a standard anti-inflammatory drug, 
and its anti-inflammatory activity was measured as compared with the control group of animals that 
received the same amount of normal saline. Indomethacin and saline were given orally, 1 h before 
the carrageenan was injected. Data is expressed as mean ± S.D. The data was subjected to one–way 
analysis of variance (ANOVA) followed by Dunnett’s test. Differences between two means were 
detected by Student t-test. Data were considered significantly different for p < 0.05. 
4.9. Drosophila Toxicity Tests 
Larvae of Drosophila melanogaster Oregon-RC (wild-type flies, stock no. 5) ("Bloomington 
Drosophila Stock Center", Indiana University, USA) fruit flies were used for toxicity testing. Fruit flies 
were cared for, grown, fed, mated and transferred to the treatment media as previously described 
[30]. Larvae aged 72 ± 4 h were washed with distilled water and transferred to the standard feeding 
media containing 0, 0.19, 0.38, 0.75, 1.5 or 3% v/v of either rhizome or leaf oil extract from P. hybridus. 
Each experimental/control group consisted of 3 replicas. Each replica contained 20 larvae. Number 
of pupae, hatched adults and adult mortality were recorded daily. The exposure period lasted until 
all individuals that were alive emerged from pupae, i.e., 7 and 13 days for the rhizome and leaf 
essential oil extracts, respectively. As each of the adults emerged from its pupae it was immediately 
transferred to a new essential oil extract-free feeding medium. Hatched adults were monitored for an 
additional 7 (rhizome oil group) or 14 (leaf oil group) days after emergence for any prolonged effects 
on adulthood survival. 
Risk Assessment Tool Analysis Software RA V1.0 was used to predict the short term LC50 (the 
lethal concentration required to kill 50% of the experimental population at a given time) by using 
surface response model analysis of the results for the P. hybridus rhizome and leaf extracts after 
subchronic exposure. Furthermore, the chronic toxicity threshold (LC1) was derived for the D. 
melanogaster (larva to adult). Development time (larva to pupa; larva to adult) was calculated for each 
replica of 20 eggs (N = 3) according to the following equation: DT = ∑nd*d/nt, where nd is the number 
of pupating larvae/emerging flies d days after the eggs were laid, and nt is the total number of 
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individuals pupating/emerging at the end of experiment. Results were analyzed by one-way ANOVA 
followed by Tukey's test and Dunnett's procedure if significant. In addition, frequency analysis was 
performed by pooling together three replicas (total N = 60 per concentration) and results were expressed 
as categorical data (1—pass, or 0—fail). A chi-square test was conducted to assess significant differences 
in the relative mortality or pupation frequencies. If significant, after residual analysis, Fischer's exact 
test was used to compare specific 2 x 2 tables and assess differences in the relative frequencies. Only a 
p value of ≤ 0.05 was considered statistically significant. 
5. Conclusions 
Pyrrolizidine alkaloids were not present in the essential oil of P. hybridus subsp. ochroleucus; 
concentrations of sesquiterpene esters were moderate, and sesquiterpene esters were present only in 
the rhizome’s essential oil, while essential oil from the leaves had high concentrations of 
sesquiterpene lactones. The essential oils showed no signs of toxicity to mice and no skin irritation 
potential in humans, and had no antimicrobial properties. However, they were found to have good 
local anti-inflammatory activity, a potential for use as an efficient insect repellent (leaves’ essential 
oils) and a potential value for the treatment of neurological disorders, due to their anticholinergic 
activity. 
Supplementary Materials: The following are available online at www.mdpi.com/2223-7747/9/6/700/s1, Figure 
S1. TIC Chromatogram of rhizome essential oil (Numbers above the peaks corresponding to the numbers in 
Table 1, Figure S2: Extracted spectrum for the compound No. 54, identified as 7-epi-α-Eudesmol, Figure S3: 
Extracted spectrum for the compound No. 60, identified as Isopetasine, Figure S4: Extracted spectrum for the 
compound No. 61, identified as Fukinanolide. 
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